Dexamethasone/levofloxacin, sold under the brand name Levodexa, is a fixed-dose combination medication used for the prevention and treatment of inflammation, and the prevention of infection, associated with cataract surgery. It contains dexamethasone, a corticosteroid; and levofloxacin, an anti-infective.
It was approved for medical use in Canada in December 2023.
Medical uses Dexamethasone/levofloxacin is indicated for the prevention and treatment of inflammation, and the prevention of infection, associated with cataract surgery in adults.
References